Introduction Semaglutide Has revolutionized the treatment of type 2 diabetes and obesity, offering a unique combination of benefits for weight management, blood sugar control, and cardiovascular protection. As a GLP-1 receptor agonist, it mimics the natural hormone glucagon-like peptide-1, which regulates critical processes such as appetite, insulin secretion, and glucose https://cancer-second-opinion83603.dsiblogger.com/64478118/semaglutide-a-revolutionary-treatment-for-diabetes-obesity-and-cardiovascular-health